Compelling Advantages Of Creating A Patient-Centric Supply Chain

By Nina Vas, Vice President, Clinical Distribution, Marken

In 2020, the prospect of shipping perishable COVID-19 vaccines around the globe pushed the pharmaceutical cold chain into the spotlight. The requirement for trustworthy, climate-controlled transportation and storage at an unprecedented scale and reach called attention to the complexities surrounding the worldwide distribution of temperature-sensitive medicines and clinical trial materials (CTMs).

Patient wellbeing and clinical trial success both hinge on efficient, compliant CTM distribution and administration. When combined with robust infrastructure, global experience, and innovative packaging solutions, the storage of supplies and clinical drug products close to patients, when appropriate, can be a key strategy.

Marken’s Vice President, Clinical Distribution, Nina Vas, discusses everything from global regulatory and trade compliance proficiency to the importance of a secure, closed-loop environment as she evaluates what is needed to develop a patient-centric supply chain.